Supernus Pharmaceuticals (SUPN) Invested Capital (2011 - 2025)
Supernus Pharmaceuticals (SUPN) posted quarterly Invested Capital of $31.1 million for Q4 2025, down 34.41% year-over-year from $47.3 million in Q4 2024, and up 176.39% on a QoQ basis from $11.2 million in Q3 2025.
Supernus Pharmaceuticals (SUPN) Invested Capital (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals has reported Invested Capital for 9 years, with the latest figure at $31.1 million in Q4 2025.
- Invested Capital for Q4 2025 came in at $31.1 million, down 34.41% year-over-year; the trailing twelve-month figure through Jun 2026 was $42.3 million (down 65.88% YoY), and the FY2025 annual result was $31.1 million, down 34.41% from the prior year.
- Invested Capital improved to $31.1 million in Q4 2025, from $11.2 million in the prior quarter.
- Over five years, Invested Capital peaked at $401.4 million in Q3 2022 and troughed at $11.2 million in Q3 2025.
- A 5-year average of $76.6 million and a median of $45.9 million in 2023 frame the typical range for Invested Capital.
- The widest annual swing landed in 2022, when Invested Capital jumped 1603.17%; it then plunged 94.83% in 2023.
- A 5-year view of Invested Capital shows it stood at $44.8 million in 2021, then tumbled by 52.9% to $21.1 million in 2022, then jumped by 146.54% to $52.1 million in 2023, then decreased by 9.08% to $47.3 million in 2024, then slumped by 34.41% to $31.1 million in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $31.1 million in Q4 2025, $11.2 million in Q3 2025, and $30.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.05 Mn |
| Sep 30, 2025 | 11.24 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Dec 31, 2024 | 47.34 Mn |
| Sep 30, 2024 | 46.58 Mn |
| Jun 30, 2024 | 47.30 Mn |
| Mar 31, 2024 | 51.38 Mn |
| Dec 31, 2023 | 52.07 Mn |
| Sep 30, 2023 | 45.88 Mn |
| Jun 30, 2023 | 20.72 Mn |
| Mar 31, 2023 | 78.36 Mn |
| Dec 31, 2022 | 21.12 Mn |
| Sep 30, 2022 | 47.59 Mn |
| Jun 30, 2022 | 47.24 Mn |
| Mar 31, 2022 | 46.89 Mn |
| Dec 31, 2021 | 44.84 Mn |
| Sep 30, 2021 | 23.57 Mn |
| Jun 30, 2021 | 23.54 Mn |
| Mar 31, 2021 | 31.52 Mn |
| Dec 31, 2020 | 30.90 Mn |